29 June 2020
Statement from the Chief Investigators: no clinical benefit from use of lopinavir-ritonavir in hospitalised COVID-19 patients studied in RECOVERY
5 October 2020
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial published in The Lancet
